Prostate IMRT fractionation strategies: Two-phase treatment versus simultaneous integrated boost

Radiology and Oncology

Volumn 37, Issue 2, 2003, Pages

  Stavrev, Pavel ^a,b   Hristov, Dimitre ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

Dose fractionation; Prostatic neoplasms radiotherapy; Radiotherapy dosage; Radiotherapy, conformal

Indexed keywords

ARTICLE; CALCULATION; CANCER CONTROL; CANCER RADIOTHERAPY; CASE REPORT; CLONOGENESIS; DOSIMETRY; HUMAN; MALE; PROBABILITY; PROSTATE TUMOR; RADIATION DOSE; TREATMENT PLANNING;

EID: 0037491615     PISSN: 13182099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Mohan R, Wu Q, Manning M, Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 2000; 46: 619-30.
2. Wu Q, Manning M, Schmidt-Ullrich R, Mohan R. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000; 46: 195-205.
3. Lebesque JV, Keus RB. The simultaneous boost technique: the concept of relative normalized total dose. Radiother Oncol 1991; 22: 45-55.
4. Knee R, Fields RS, Peters LJ. Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1985; 4: 1-7.
5. Heukelom S, Lanson JH, Mijnheer BJ. Quality assurance of the simultaneous boost technique for prostatic cancer: dosimetric aspects. Radiother Oncol 1994; 30: 74-82.
6. Essers M, Lanson JH, Mijnheer BJ. In vivo dosimetry during conformal therapy of prostatic cancer. Radiother Oncol 1993; 29: 271-9.
7. Stavrev PV, Hristov DH, Seuntjens JP. On the consistent use of organ definitions and radiobiological models for the evaluation of complication probabilities of tubular organs. Int J Radiat Oncol Biol Phys 2002; 52: 1150-2.
8. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991; 21: 123-35.
9. Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys 1995; 32: 1227-37.
10. Stavrev P, Stavreva N, Niemierko A, Goitein M. The Application of biological models to clinical data.. Phys Medica 2001; 17: 71-82.
11. Dale E, Hellebust TP, Skjonsberg A, Hogberg T, Olsen DR. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix. Int J Radiat Oncol Biol Phys 2000; 47: 963-71.
12. Brenner DJ. Toward optimal external-beam fractionation for prostate cancer. Int J Radiat Oncol Biol Phys 2000; 48: 315-6.
13. Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999; 43: 1095-101.
14. King CR, Mayo CS. Is the prostrate alpha/beta ratio of 1.5 from Brenner & Hall a modeling artifact. Int J Radiat Oncol Biol Phys 2000; 47: 536-9.
15. Brenner DJ, Hall EJ. In response to Drs. King and Mayo: Low alpha/beta values for prostate appear to be independent of modeling details. Int J Radiat Oncol Biol Phys 2000; 47: 538-9.
16. Logue JP, Cowan RA, Hendry JH. Hypofractionation for prostate cancer. Int J Radiat Oncol Biol Phys 2001; 49: 1522-3.
17. Brenner DJ. Hypofractionation for prostate cancer - In response. Int J Radiat Oncol Biol Phys 2001; 49: 1522-3.
18. Dale E, Olsen DR, Fossa SD. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys 1999; 43: 385-91.
19. Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res 1985; 8(Suppl 1): S13-9.
20. Niemierko A, Goitein M. Modeling of normal tissue response to radiation: the critical volume model. Int J Radiat Oncol Biol Phys 1993; 25: 135-45.
21. Jackson A, Kutcher GJ, Yorke ED. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys 1993; 20: 613-25.
22. Yorke ED, Kutcher GJ, Jackson A, Ling CC. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol 1993; 26: 226-37.
23. Jackson A, Ten Haken RK, Robertson JM, Kessler ML, Kutcher GJ, Lawrence TS. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 1995; 31: 883-91.
24. Niemierko A. Present and future of the clinical use of radiobiological models in radiation therapy treatment planning. Phys Medica 1997; 13: 34-8.
25. Stavrev P, Stavreva N, Niemierko A, Goitein M. Generalization of a model of tissue response to radiation based on the idea of functional subunits and binomial statistics. Phys Med Biol 2001; 46: 1501-18.
26. Niemierko A, Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. Radiother Oncol 1991; 20: 166-76.
27. Lyman JT, Wolbarst AB. Optimization of radiation therapy, III: a method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys 1987; 13: 103-9.
28. Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 1991; 21: 137-46.
29. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 1989; 16: 1623-30.
30. Niemierko A. A generalized concept of Equivalent Uniform Dose. [Abstract]. 41th AAPM Annual Meeting, Nashville, 24-29 July. Med Phys 1999; 26: 1100.
31. Lebesque JV, Bruce AM, Kroes AP, Touw A, Shouman RT, van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys 1995; 33: 1109-19.
32. Ting JY, Wu X, Fiedler JA, Yang C, Watzich ML, Markoe A. Dose-volume histograms for bladder and rectum. Int J Radiat Oncol Biol Phys 1997; 38: 1105-11.
33. Boersma LJ, van den Brink M, Bruce AM, Shouman T, Gras L, te Velde A, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 1998; 41: 83-92.
34. Jackson A, Skwarchuk MW, Zelefsky MJ, Cowen DM, Venkatraman ES, Levegrun S, et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 2001; 49: 685-98.
35. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21: 109-22.
36. Hartford AC, Niemierko A, Adams JA, Urie MM, Shipley WU. Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms. Int J Radiat Oncol Biol Phys 1996; 36: 721-30.
37. Stavrev PV, Stavreva NA, Round WH. A new method for optimum dose distribution determination taking tumour mobility into account. Phys Med Biol 1996; 41: 1679-89.
38. Lind BK, Kallman P, Sundelin B, Brahme A. Optimal radiation beam profiles considering uncertainties in beam patient alignment. Acta Oncol 1993; 32: 331-42.
39. Lof J, Lind BK, Brahme A. An adaptive control algorithm for optimization of intensity modulated radiotherapy considering uncertainties in beam profiles, patient set-up and internal organ motion. Phys Med Biol 1998; 43: 1605-28.
40. Mageras GS, Kutcher GJ, Leibel SA, Zelefsky MJ, Melian E, Mohan R, et al. A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans. Int J Radiat Oncol Biol Phys 1996; 35: 333-42.
41. Rudat V, Schraube P, Oetzel D, Zierhut D, Flentje M, Wannenmacher M. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 1996; 35: 1027-34.